The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Timoshenko O.S.

V.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences

Gureeva T.A.

V.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences

Kugaevskaya E.V.

V.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Solovуeva N.I.

V.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences

The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma

Authors:

Timoshenko O.S., Gureeva T.A., Kugaevskaya E.V., Zavalishina L.É., Andreeva Yu.Yu., Solovуeva N.I.

More about the authors

Read: 1489 times


To cite this article:

Timoshenko OS, Gureeva TA, Kugaevskaya EV, Zavalishina LÉ, Andreeva YuYu, Solovуeva NI. The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma. Russian Journal of Archive of Pathology. 2019;81(6):34‑40. (In Russ.)
https://doi.org/10.17116/patol20198106134

References:

  1. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55(2):434-439.
  2. Knutti N, Kuepper M, Friedrich K. Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147. FEBS J. 2015;282(21):4187-4200. https://doi.org/10.1111/febs.13414
  3. Uspenskaya YuA, Komleva YuK, Gorina YaV, Pozhilenkova EA, Belova OA, Salmina AB. CD147 polyfunctionality and new diagnostic and therapy opportunities. Sibirskoe meditsinskoe obozrenie. 2018;4:22-30. (In Russ.) https://doi.org/10.20333/2500136-2018-4-22-30
  4. Xin X, Zeng X, Gu H, Li M, Tan H, Jin Z, Hua T, Shi R, Wang H. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and metaanalysis. Sci Rep. 2016;6:32804. https://doi.org/10.1038/srep32804
  5. Aoki M, Koga K, Hamasaki M, Egawa N, Nabeshima K. Emmprin, released as a microvesicle in epithelioid sarcoma, interacts with fibroblasts. Int J Oncol. 2017;50(6):2229-2235. https://doi.org/10.3892/ijo.2017.3986
  6. Futamura N, Nishida Y, Urakawa H, Kozawa E, Ikuta K, Hamada S, Ishiguro N. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. Tumor Biol. 2014;35(6):5159-5165. https://doi.org/10.1007/s13277-014-1668-8
  7. Wang Z, Zhao Z, Jiang T. The multistep functions of EMMPRIN/CD147 in the tumor angiogenesis. Cell Mol Med. 2016;2:1. https://doi.org/10.21767/2573-5365.100012
  8. Grass GD, Toole BP. How, with whom and when: an overview of CD147 mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep. 2015;36(1):e00283. https://doi.org/10.1042/BSR20150256
  9. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-839. https://doi.org/10.1161/01.RES.0000070112.80711.3D
  10. Amar S, Smith L, Fields GB. Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta. 2017;1864 (11 Pt A):1940-1951. https://doi.org/10.1016/j.bbamcr.2017.04.015
  11. Solovyeva NI, Timoshenko OS, Gureeva TA, Kugaevskaya EV. Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (Review of the own data). Biomeditsinskaya khimiya.2015;61(6):694-704. (In Russ.) https://doi.org/10.18097/PBMC20156106694
  12. Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012;181(6):1895-1899. https://doi.org/10.1016/j.ajpath.2012.08.044
  13. Timoshenko OS, Gureeva TA, Kugaevskaya EV, Zavalishina LE, Solovyeva NI. Interstitial collagenase and their endogenous regulators in squamous cell cervical carcinoma. Biomeditsinskaya khimiya. 2017;63(6):513-519. (In Russ.). https://doi.org/10.18097/PBMC20176306513
  14. ZurHausen H. Papillomavirus infections — a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55-F78. https://doi.org/10.1016/0304-419X(96)00020-0
  15. ZurHausen H. Papillomaviruses in the causation of human cancers — a brief historical account. Virology. 2009;384(2):260-265. https://doi.org/10.1016/j.virol.2008.11.046
  16. Timoshenko OS, Gureeva TA, Kugaevskaya EV, Zavalishina LE, Andreeva YuYu, Solovyeva NI. Gelatinases A and B and their endogenous regulators in the body of the uterus in squamous cell carcinoma of the cervix. Arkhiv patologii. 2018;80(6):22-28. (In Russ.). https://doi.org/10.17116/patol20188006122
  17. Dabbs D. Diagnostic Immunohistochemistry. 2nd ed. Philadelphia. 2006.
  18. Ryzhakova OS, Zavalishina LE, Andreeva YuYu, Solovyeva NI. Interstitial collagenase, gelatinases A and B and their endogenous inhibitors in squamous cell cervical carcinomas. Biomeditsinskayakhimiya.2013;59(1):55-64. (In Russ.) https://doi.org/10.18097/pbmc20135901055
  19. Timoshenko OS, Gureeva TA, Kugaevskaya EV, Solovyeva NI. Membrane type 1 matrix metalloproteinase (MT1-MMP) and its endogenous regulators as invasive factors in squamous cell cervical carcinoma. Biochemistry (Moscow) Supplement. Series B: Biomedical Chemistry. 2015;9(4):351-354.
  20. Ryzhakova OS, Gureeva TA, Zhurbitskaya VA, Solovyeva NI. Expression of interstitial collagenase and its endogenous regulators in immortalized and transformed by E7 gene HPV-16 fibroblasts. Biomeditsinskaya khimiya. 2007;53(3):322-331. (In Russ.) Received 20.05.19

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.